Filing Flows › Zoetis (ZTS) › R&D spending
Zoetis (ZTS) R&D spending by quarter
Zoetis' R&D spending was $174M in Q3 2026 (third quarter 2026), +0.6% from Q2 2026. Over the last 7 quarters it ranged from $162M (Q1 2025) to $195M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $174M | +0.6% | -0.6% |
| Q2 2026 | $173M | -4% | +4% |
| Q1 2026 | $180M | -8% | +11% |
| Q4 2025 | $195M | +11% | — |
| Q3 2025 | $175M | +5% | — |
| Q2 2025 | $166M | +2% | — |
| Q1 2025 | $162M | — | — |
Q3 2026 at a glance
Zoetis, Q3 2026: revenue $2.4B (-1% year over year), operating margin 30.5%, net earnings $591M, operating cash flow $824M. The chart follows the revenue to costs, profit and cash.
Questions
What is Zoetis' R&D spending?
Zoetis' R&D spending was $174M in Q3 2026 (third quarter 2026), +0.6% from Q2 2026.
How has Zoetis' R&D spending changed?
Over the last 7 quarters it ranged from $162M (Q1 2025) to $195M (Q4 2025).